Dasatinib Dr. Reddy's dasatinib 50 mg film coated tablet blister pack and Dasatinib Dr. Reddy's dasatinib 100 mg film coated tablet blister pack
Published 14 October 2022
Product
Dasatinib Dr. Reddy's dasatinib 50 mg film coated tablet blister pack Batch No. ZH20021 (50mg); Product Code: 36456 Expiry date: 06/2023 Dasatinib Dr. Reddy's dasatinib 100 mg film coated tablet blister pack Batch No. ZH20023 (100mg); Product Code: 36458 Expiry date: 12/2023 ARTG 337451 (Dasatinib Dr. Reddy's dasatinib 50 mg film coated tablet blister pack) ARTG 337460 (Dasatinib Dr. Reddy's dasatinib 100 mg film coated tablet blister pack) Prescription only medicine for for the treatment of chronic myeloid leukaemia (CML). It is also used to treat a particular form of acute lymphoblastic leukaemia (ALL) called Philadelphia chromosome positive or Ph+ ALL.
Why it was recalled
The tablet may not dissolve properly and this can result in incomplete release of the medicine.
Hazard
If patients receive a lower dose of the medicine than prescribed, the medicine may be less effective, increasing the risk of serious adverse health effects.
Source: Based on ACCC data or other content. ACCC © Commonwealth of Australia. ACCC-owned material is licensed under CC BY 4.0. RecallMatch extracts and formats notice information for screening. Third-party material may have separate rights. Source and reuse terms. Verify details in the official notice. RecallMatch is independent of the ACCC.